Warning letter
Sincerus Florida, LLC: warning letter of Dec 21, 2016
FDA warning letter 507593 · Florida District Office
Key facts
| Reference number | 507593 |
|---|---|
| Company | Sincerus Florida, LLC |
| Subject | Unapproved New Drugs/Misbranded |
| Issue date | Dec 21, 2016 |
| Posted date | Feb 7, 2017 |
| Issuing office | Florida District Office |
| Product type | Drugs |
| CFR sections cited | 201.115 |
| Inspection city | Pompano Beach |
| Inspection ZIP | 33069 |
| Inspection start date | Jul 12, 2016 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: